Aadi Bioscience Statistics
Share Statistics
Aadi Bioscience has 24.65M shares outstanding. The number of shares has increased by 0.36% in one year.
| Shares Outstanding | 24.65M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.25% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.09M |
| Failed to Deliver (FTD) Shares | 670 |
| FTD / Avg. Volume | 0.57% |
Short Selling Information
The latest short interest is 281.12K, so 1.14% of the outstanding shares have been sold short.
| Short Interest | 281.12K |
| Short % of Shares Out | 1.14% |
| Short % of Float | 1.4% |
| Short Ratio (days to cover) | 3.24 |
Valuation Ratios
The PE ratio is -0.83 and the forward PE ratio is -2.15.
| PE Ratio | -0.83 |
| Forward PE | -2.15 |
| PS Ratio | 2.23 |
| Forward PS | 2.1 |
| PB Ratio | 0.52 |
| P/FCF Ratio | -0.85 |
| PEG Ratio | n/a |
Enterprise Valuation
Aadi Bioscience Inc. has an Enterprise Value (EV) of -1.49M.
| EV / Earnings | 0.02 |
| EV / Sales | -0.06 |
| EV / EBITDA | 0.02 |
| EV / EBIT | 0.02 |
| EV / FCF | 0.02 |
Financial Position
The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.
| Current Ratio | 4.72 |
| Quick Ratio | 4.48 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -311.4 |
Financial Efficiency
Return on equity (ROE) is -0.63% and return on capital (ROIC) is -67.57%.
| Return on Equity (ROE) | -0.63% |
| Return on Assets (ROA) | -0.5% |
| Return on Capital (ROIC) | -67.57% |
| Revenue Per Employee | 459.51K |
| Profits Per Employee | -1.24M |
| Employee Count | 53 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.44 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 2.56% in the last 52 weeks. The beta is 0.37, so Aadi Bioscience 's price volatility has been higher than the market average.
| Beta | 0.37 |
| 52-Week Price Change | 2.56% |
| 50-Day Moving Average | 2.16 |
| 200-Day Moving Average | 1.89 |
| Relative Strength Index (RSI) | 60.17 |
| Average Volume (20 Days) | 116.99K |
Income Statement
In the last 12 months, Aadi Bioscience had revenue of $24.35M and earned -$65.77M in profits. Earnings per share was $-2.44.
| Revenue | 24.35M |
| Gross Profit | 21.55M |
| Operating Income | -71.93M |
| Net Income | -65.77M |
| EBITDA | -65.36M |
| EBIT | -71.93M |
| Earnings Per Share (EPS) | -2.44 |
Balance Sheet
The company has $62.89M in cash and $1.27M in debt, giving a net cash position of $61.62M.
| Cash & Cash Equivalents | 62.89M |
| Total Debt | 1.27M |
| Net Cash | 61.62M |
| Retained Earnings | -268.96M |
| Total Assets | 85.70M |
| Working Capital | 61.50M |
Cash Flow
In the last 12 months, operating cash flow was -$59.66M and capital expenditures -$3.97M, giving a free cash flow of -$63.63M.
| Operating Cash Flow | -59.66M |
| Capital Expenditures | -3.97M |
| Free Cash Flow | -63.63M |
| FCF Per Share | -2.36 |
Margins
Gross margin is 88.47%, with operating and profit margins of -295.36% and -270.04%.
| Gross Margin | 88.47% |
| Operating Margin | -295.36% |
| Pretax Margin | -270.04% |
| Profit Margin | -270.04% |
| EBITDA Margin | -268.4% |
| EBIT Margin | -295.36% |
| FCF Margin | -261.29% |
Dividends & Yields
AADI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -101.67% |
| FCF Yield | -107.38% |
Analyst Forecast
The average price target for AADI is $1.75, which is -27.1% lower than the current price. The consensus rating is "Hold".
| Price Target | $1.75 |
| Price Target Difference | -27.1% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Aug 27, 2021. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 27, 2021 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -4.2 |
| Piotroski F-Score | 3 |